{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T14:54:37Z","timestamp":1648652077931},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2016,5,24]],"date-time":"2016-05-24T00:00:00Z","timestamp":1464048000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Chin. J. Integr. Med."],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1007\/s11655-016-2582-2","type":"journal-article","created":{"date-parts":[[2016,5,24]],"date-time":"2016-05-24T16:51:01Z","timestamp":1464108661000},"page":"573-580","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Short-term efficacy of treating hepatitis B virus-related acute-on-chronic liver failure based on cold pattern differentiation with hot herbs: A randomized controlled trial"],"prefix":"10.1007","volume":"22","author":[{"given":"Yu-ming","family":"Guo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng-yi","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Man","family":"Gong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia-bo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-he","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan-ling","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-fu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-feng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,5,24]]},"reference":[{"key":"2582_CR1","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1586\/egh.11.47","volume":"5","author":"W Laleman","year":"2011","unstructured":"Laleman W, Verbeke L, Meersseman P, Wauters J, van Pelt J, Cassiman D, et al. Acute-on-chronic liver failure:current concepts on definition, pathogenesis, clinical manifestations and potential therapeutic interventions. Expert Rev Gastroenterol Hepatol 2011;5:523\u2013537.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"2582_CR2","first-page":"643","volume":"14","author":"Liver FailureArtificial Liver Group, Chinese Society of Infectious Diseases, Chinese Medical Association; Severe Liver DiseasesArtificial Liver Group, Chinese Society of Hepatology.","year":"2006","unstructured":"Liver Failure and Artificial Liver Group, Chinese Society of Infectious Diseases, Chinese Medical Association; Severe Liver Diseases and Artificial Liver Group, Chinese Society of Hepatology. Diagnostic and treatment guidelines for liver failure. Chin J Hepatol (Chin) 2006;14:643\u2013646.","journal-title":"Chin J Hepatol (Chin)"},{"key":"2582_CR3","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1097\/00029330-200712020-00001","volume":"120","author":"JD Jia","year":"2007","unstructured":"Jia JD, Zhuang H. A winning war against hepatitis B virus infection in China. Chin Med J 2007;120:2157\u20132158.","journal-title":"Chin Med J"},{"key":"2582_CR4","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1159\/000232940","volume":"28","author":"Q Liu","year":"2009","unstructured":"Liu Q. Role of Cytokines in the Pathophysiology of acuteon-chronic liver failure. Blood Purif 2009;28:331\u2013341.","journal-title":"Blood Purif"},{"key":"2582_CR5","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1055\/s-2008-1040324","volume":"28","author":"V Stadlbauer","year":"2008","unstructured":"Stadlbauer V, Davies NA, Sen S, Jalan R. Artificial liver support systems in the management of complications of cirrhosis. Semin Liver Dis 2008;28:96\u2013109.","journal-title":"Semin Liver Dis"},{"key":"2582_CR6","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1365-2036.2006.02765.x","volume":"23","author":"W Laleman","year":"2006","unstructured":"Laleman W, Wilmer A, Evenepoel P, Verslype C, Fevery J, Nevens F. Review article: non-biological liver support in liver failure. Aliment Pharmacol Ther 2006;23:351\u2013363.","journal-title":"Aliment Pharmacol Ther"},{"key":"2582_CR7","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1159\/000047017","volume":"20","author":"R Jalan","year":"2002","unstructured":"Jalan R, Williams R. Acute-on-chronic liver failure: pathophysiological basis of therapeutic options. Blood Purif 2002;20:252\u2013261.","journal-title":"Blood Purif"},{"key":"2582_CR8","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/nature02626","volume":"429","author":"WE Evans","year":"2004","unstructured":"Evans WE, Relling MV. Moving towards individualized medicine with pharmacogenomics. Nature 2004;429:464\u2013468.","journal-title":"Nature"},{"key":"2582_CR9","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/448126a","volume":"448","author":"J Qiu","year":"2007","unstructured":"Qiu J. Traditional medicine: a culture in the balance. Nature 2007;448:126\u2013128.","journal-title":"Nature"},{"key":"2582_CR10","volume-title":"Chinese pharmacy","year":"2008","unstructured":"Lei ZQ, Chen SY, Gao XM, eds. Chinese pharmacy. Shanghai: Shanghai Science and Technology Press; 2008."},{"key":"2582_CR11","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.jep.2014.03.039","volume":"153","author":"Q Wang","year":"2014","unstructured":"Wang Q, Jiang P, Ye FY, Shi R, Ma YM, Zhong J, et al. Identification and pharmacokinetics of multiple constituents in rat plasma after oral administration of Yinchenzhufu Decoction. J Ethnopharmacol 2014;153:714\u2013724.","journal-title":"J Ethnopharmacol"},{"key":"2582_CR12","first-page":"23","volume":"3","author":"HY Yang","year":"2008","unstructured":"Yang HY. Two cases for treatment of yin-jaundice by Yinchen Zhufu Decoction. J Chin Med Clin 2008;3:23.","journal-title":"J Chin Med Clin"},{"key":"2582_CR13","volume-title":"Pharmacopoeia of the People\u2019s Republic of China","author":"China Pharmacopoeia Commission.","year":"2005","unstructured":"China Pharmacopoeia Commission. Pharmacopoeia of the People\u2019s Republic of China. Beijing: Chemical Industry Press;2005."},{"key":"2582_CR14","first-page":"981","volume":"26","author":"KW Sun","year":"2006","unstructured":"Sun KW, Chen B, Huang YH. Clinical observation on chronic severe hepatitis B treated by principles of coolingblood and detoxicating combined with clearing-heat and resolving-damp or combined with strengthening-Pi and warming-yang. Chin J Integr Tradit West Med (Chin) 2006;26:981\u2013983.","journal-title":"Chin J Integr Tradit West Med (Chin)"},{"key":"2582_CR15","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s12072-008-9106-x","volume":"3","author":"KS Shiv","year":"2009","unstructured":"Shiv KS, Ashish K, John AA, Chawla YK, Fan ST, Garg H, et al. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL). Hepatol Int 2009;3:269\u2013282.","journal-title":"Hepatol Int"},{"key":"2582_CR16","unstructured":"Zheng XY, ed. Guiding principle of clinical research on new drugs of Chinese medicine (trial implementation). Beijing: Chinese Medical Science and Technology Press; 2002."},{"key":"2582_CR17","volume-title":"Chinese internal medicine","year":"1998","unstructured":"Wang YY, Li MF, Dai XM, eds. Chinese internal medicine. Shanghai: Shanghai Scientific and Technical Publishers;1998."},{"key":"2582_CR18","unstructured":"ICH Good Clinical Practices. Available at: http:\/\/www. vadscorner.com\/internet29.html."},{"key":"2582_CR19","first-page":"477","volume":"15","author":"SQ Luo","year":"2007","unstructured":"Luo SQ, Zhang LX. AASLD practice guidelines: chronic Hepatitis B. Chin J Hepatol (Chin) 2007;15:477\u2013480.","journal-title":"Chin J Hepatol (Chin)"},{"key":"2582_CR20","volume-title":"Diagnosis and curing criteria of clinical diseases","author":"Ministry of Health, General Logistics Department of PLA.","year":"2002","unstructured":"Ministry of Health, General Logistics Department of PLA. Diagnosis and curing criteria of clinical diseases (2nd ed). Beijing: People\u2019s Military Medical Press; 2002."},{"key":"2582_CR21","volume-title":"Hepatology: a textbook of liver disease","year":"2006","unstructured":"Sanyal AJ, Stravitz RT, eds. Hepatology: a textbook of liver disease. 5th ed. Philadelphia: Saunders Elsevier;2006."},{"key":"2582_CR22","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.hepres.2004.02.015","volume":"29","author":"SH Bui Han","year":"2004","unstructured":"Bui Han SH, Martin P. Liver transplantation for hepatitis B. Hepatol Res 2004;29:193\u2013201.","journal-title":"Hepatol Res"},{"key":"2582_CR23","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1016\/j.cgh.2006.07.014","volume":"4","author":"A Rutherford","year":"2006","unstructured":"Rutherford A, Davern T, Hay JE, Murray NG, Hassanein T, Lee WM, et al. Influence of high body mass index on outcome in acute liver failure. Clin Gastroenterol Hepatol 2006;4:1544\u20131549.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2582_CR24","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.jhep.2003.11.020","volume":"40","author":"W Bernal","year":"2004","unstructured":"Bernal W, Wendon J. Liver transplantation in adults with acute liver failure. J Hepatol 2004;40:192\u2013197.","journal-title":"J Hepatol"},{"key":"2582_CR25","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/ajg.2009.593","volume":"105","author":"RS O\u2019Shea","year":"2010","unstructured":"O\u2019Shea RS, Dasarathy S, McCullough AJ. Alcoholic liver disease. Am J Gastroenterol 2010;105:14\u201332.","journal-title":"Am J Gastroenterol"},{"key":"2582_CR26","doi-asserted-by":"crossref","first-page":"725","DOI":"10.2165\/00002512-200118100-00002","volume":"18","author":"P Merle","year":"2001","unstructured":"Merle P, Tr\u00e9po C, Zoulim F. Current management strategies for hepatitis B in the elderly. Drugs Aging 2001;18:725\u2013735.","journal-title":"Drugs Aging"},{"key":"2582_CR27","first-page":"2109","volume":"53","author":"ZQ Dang","year":"2012","unstructured":"Dang ZQ, Yang GH, Ma YJ, Zhao CP, Yu JZ, Xi YH, et al. Synergistic effect of multi-ways Chinese medication on routine therapy for hepatitis B virus related acute-on-chronic liver failure. J Tradit Chin Med (Chin) 2012;53:2109\u20132111.","journal-title":"J Tradit Chin Med (Chin)"},{"key":"2582_CR28","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1111\/j.1440-1746.2006.04362.x","volume":"22","author":"Q Liu","year":"2007","unstructured":"Liu Q, Liu Z, Wang T, Wang Q, Shi X, Dao W. Characteristics of acute and sub-acute liver failure in China: nomination, classification and interval. J Gastroenterol Hepatol 2007;22:2101\u20132106.","journal-title":"J Gastroenterol Hepatol"},{"key":"2582_CR29","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1053\/he.2000.5852","volume":"31","author":"M Malinchoc","year":"2000","unstructured":"Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. J Hepatol 2000;31:864\u2013871.","journal-title":"J Hepatol"},{"key":"2582_CR30","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1053\/jhep.2001.22172","volume":"33","author":"PS Kamath","year":"2001","unstructured":"Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL. A model to predict survival in patients with end-stage liver disease. J Hepatol 2001;33:464\u2013470.","journal-title":"J Hepatol"},{"key":"2582_CR31","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/hep.21563","volume":"45","author":"PS Kamath","year":"2007","unstructured":"Kamath PS, Kim WR. The model for end-stage liver disease (MELD). J Hepatol 2007;45:797\u2013805.","journal-title":"J Hepatol"},{"key":"2582_CR32","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1016\/j.transproceed.2006.06.004","volume":"38","author":"MB Zaman","year":"2006","unstructured":"Zaman MB, Hoti E, Qasim A, Maguire D, McCormick PA, Hegarty JE, et al. MELD score as a prognostic model for listing acute liver failure patients for liver transplantation. Transplant Proc 2006;38:2097\u20132098.","journal-title":"Transplant Proc"},{"key":"2582_CR33","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1432-2277.2004.00024.x","volume":"18","author":"G Santori","year":"2005","unstructured":"Santori G, Andorno E, Morelli N, Antonucci A, Bottino G, Mondello R, et al. MELD score versus conventional UNOS status in predicting short-term mortality after liver transplantation. Transpl Int 2005;18:65\u201372.","journal-title":"Transpl Int"},{"key":"2582_CR34","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/hep.20503","volume":"41","author":"W Dunn","year":"2005","unstructured":"Dunn W, Jamil LH, Brown LS, Wiesner RH, Kim WR, Menon KV, et al. MELD accurately predicts mortality in patients with alcoholic hepatitis. J Hepatol 2005;41:353\u2013358.","journal-title":"J Hepatol"},{"key":"2582_CR35","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/cmi.2011.51","volume":"9","author":"J Zhao","year":"2012","unstructured":"Zhao J, Zhang JY, Yu HW, He YL, Zhao JJ, Li J, et al. Improved survival ratios correlate with myeloid dendritic cell restoration in acute-on-chronic liver failure patients receiving methylprednisolone therapy. Cell Mol Immunol 2012;9:417\u2013422.","journal-title":"Cell Mol Immunol"},{"key":"2582_CR36","first-page":"53","volume":"28","author":"Q Zhang","year":"2012","unstructured":"Zhang Q, Sun FX. Clinical analysis of 79 patients with subacute liver failure. J Clin Hepatol 2012;28:53\u201354.","journal-title":"J Clin Hepatol"},{"key":"2582_CR37","first-page":"96","volume":"23","author":"CA Cao","year":"2006","unstructured":"Cao CA, Zou ZS, Li BS, Chen JM, Zhang W, Xie H, et al. Clinical features and prognosis of 151 cases with subacute severe hepatitis. J Clin Intern Med 2006;23:96\u201397.","journal-title":"J Clin Intern Med"},{"key":"2582_CR38","doi-asserted-by":"crossref","first-page":"3448","DOI":"10.3748\/wjg.v17.i29.3448","volume":"17","author":"K Huang","year":"2011","unstructured":"Huang K, Hu JH, Wang HF, He WP, Chen J, Duan XZ, et al. Survival and prognostic factors in hepatitis B virusrelated acute-on-chronic liver failure. World J Gastroenterol 2011;17:3448\u20133452.","journal-title":"World J Gastroenterol"},{"key":"2582_CR39","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/s11655-009-0152-6","volume":"15","author":"AP Lu","year":"2009","unstructured":"Lu AP, Chen KJ. Integrative medicine in clinical practice: from pattern differentiation in traditional Chinese medicine to disease treatment. Chin J Integr Med 2009;15:152.","journal-title":"Chin J Integr Med"},{"key":"2582_CR40","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.jep.2012.01.033","volume":"140","author":"M Jiang","year":"2012","unstructured":"Jiang M, Lu C, Zhang C, Yang J, Tan Y, Lu A, et al. Syndrome differentiation in modern research of traditional Chinese medicine. J Ethnopharmacol 2012;140:634\u2013642.","journal-title":"J Ethnopharmacol"},{"key":"2582_CR41","first-page":"1294","volume":"2012","author":"M Jiang","year":"2012","unstructured":"Jiang M, Lu C, Chen G, Xiao C, Zha Q, Niu X, et al. Understanding the molecular mechanism of interventions in treating rheumatoid arthritis patients with corresponding traditional Chinese medicine patterns based on bioinformatics approach. Evid Based Complement Alternat Med 2012;2012:1294.","journal-title":"Evid Based Complement Alternat Med"}],"container-title":["Chinese Journal of Integrative Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11655-016-2582-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11655-016-2582-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11655-016-2582-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,8]],"date-time":"2019-09-08T19:24:23Z","timestamp":1567970663000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11655-016-2582-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,24]]},"references-count":41,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["2582"],"URL":"https:\/\/doi.org\/10.1007\/s11655-016-2582-2","relation":{},"ISSN":["1672-0415","1993-0402"],"issn-type":[{"value":"1672-0415","type":"print"},{"value":"1993-0402","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,24]]}}}